Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Ensuring Adherence to Batch Manufacturing Records (BMRs) – V 2.0

Posted on By

Creams: SOP for Ensuring Adherence to Batch Manufacturing Records (BMRs) – V 2.0

Standard Operating Procedure for Ensuring Adherence to Batch Manufacturing Records (BMRs)

Department Creams
SOP No. SOP/CRM/175/2025
Supersedes SOP/CRM/175/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for ensuring adherence to Batch Manufacturing Records (BMRs) during the cream manufacturing process. Proper adherence to BMRs ensures consistency, product quality, and compliance with regulatory requirements.

2. Scope

This SOP applies to all personnel involved in the manufacturing process of creams, particularly those responsible for reviewing and ensuring compliance with BMRs. It covers the documentation, verification, and approval processes necessary for batch production.

3. Responsibilities

  • Production Team: Responsible for following the instructions provided in the BMR during the production process and ensuring that all activities are documented accurately.
  • Quality Control (QC) Team: Responsible for reviewing the BMR to ensure all quality parameters are adhered to and verifying that all production steps are correctly documented.
  • Quality Assurance (QA) Team: Responsible for ensuring that the BMR is completed, signed, and verified at all stages of production. QA also ensures compliance with regulatory standards and GMP guidelines.
  • Laboratory Supervisor: Responsible
for overseeing the review of BMRs, ensuring that all specifications are met, and confirming that the product meets quality standards before approval for the next production stage.

4. Accountability

The Production Manager is accountable for ensuring that all production personnel adhere to the BMR instructions. The QA Manager is responsible for overseeing the review process and ensuring that BMRs are completed correctly and on time. The Laboratory Supervisor is accountable for reviewing the final BMR and confirming product quality before batch release.

5. Procedure

5.1 Pre-Production Setup

  1. Ensure that the correct Batch Manufacturing Record (BMR) for the specific product is available before the start of production. The BMR should reflect the most current version, and all updates must be included.
  2. Verify that the BMR is complete with all necessary sections, including raw material details, production steps, equipment specifications, and quality control checks.
  3. Ensure that all personnel involved in the production process are familiar with the BMR requirements and understand their role in documenting and following the procedures outlined in the BMR.
  4. Review the batch ticket or BMR for any special instructions regarding equipment settings, process parameters, or material handling that must be followed during production.

5.2 Production Process and BMR Documentation

  1. During the manufacturing process, ensure that all steps outlined in the BMR are followed exactly. This includes ingredient dispensing, mixing, heating, cooling, and any other critical process steps.
  2. Document all production activities, including raw material weights, equipment settings, times, and any adjustments made during the process. Each entry should include the operator’s name and the time of the entry.
  3. Ensure that all quality control tests, such as viscosity, pH, and microbial testing, are documented as per the instructions in the BMR. Include results from each test and any corrective actions taken if the results deviate from the specified limits.
  4. If any deviations from the BMR occur (e.g., changes in process parameters or material substitutions), these must be documented in the Deviation Report (Annexure-1) and reviewed by the QA team for approval.

5.3 BMR Review and Verification

  1. Upon completion of the batch production, the BMR must be reviewed by the QA team to ensure that all steps were performed correctly and that the final product meets the quality specifications outlined in the BMR.
  2. The QA team should verify that the BMR is complete and accurately reflects the entire production process. Ensure that any changes made during production (e.g., equipment adjustments, process variations) are documented and justified.
  3. Confirm that all signatures on the BMR are present, including the operator, supervisor, and QC personnel, where applicable. Each section of the BMR should be signed off at the appropriate points in the production process.
  4. Ensure that any deviations or exceptions documented during production are resolved before final approval. If necessary, initiate corrective or preventive actions as outlined in the CAPA (Corrective and Preventive Action) process.

5.4 Post-Production Activities

  1. Once the BMR is verified and complete, the QA team will approve the batch for the next stage of production, such as filling or packaging. The batch is only approved once all criteria are met, and no unresolved deviations remain.
  2. Ensure that all BMRs are archived and stored according to regulatory and company guidelines for traceability and future reference. Maintain records for a minimum of two years or as required by local regulations.

5.5 Documentation and Record-Keeping

  1. Document all batch-related activities in the BMR and ensure that the record includes accurate data on raw materials, process parameters, and testing results. Use the Batch Manufacturing Record Log (Annexure-2) for tracking each batch’s documentation status.
  2. Ensure that the BMR and related documents are signed by the relevant personnel and reviewed by the QA team. All records should be reviewed for completeness and accuracy before filing.
  3. Ensure that any deviations from the BMR, as well as the corrective actions taken, are recorded in the Deviation Report (Annexure-1). This ensures proper documentation of any incidents and the steps taken to resolve them.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • PPE: Personal Protective Equipment

7. Documents

  1. Annexure-1: Deviation Report
  2. Annexure-2: Batch Manufacturing Record Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Batch Record Documentation in Pharmaceutical Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation Report

Batch Number Deviation Description Corrective Action Resolved By
12345 Raw material substitution Verified with QA, batch approved Michael Lee

Annexure-2: Batch Manufacturing Record Log

Batch Number Document Status Signed By Date Remarks
12345 Complete John Doe 21/01/2026 Verified and signed off

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Dispensing High-Sensitivity Materials in Creams - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Filling and Sealing of Injectable Products – V 2.0
Next Post: BA-BE Studies: SOP for Reinjection of Samples – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version